BIEI (Premier Biomedical) Effective Interest Rate on Debt %: 659.49% (As of Dec. 2019)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Premier Biomedical Effective Interest Rate on Debt %?

Premier Biomedical BIEI Effective Interest Rate on Debt % is 659.49% as of Dec. 2019.

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Premier Biomedical's annualized positive value of Interest Expense for the quarter that ended in Dec. 2019 was $1.16 Mil. Premier Biomedical's average total debt for the quarter that ended in Dec. 2019 was $0.18 Mil. Therefore, Premier Biomedical's annualized Effective Interest Rate on Debt % for the quarter that ended in Dec. 2019 was 659.49%.


Premier Biomedical  (OTCPK:BIEI) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.


Premier Biomedical Effective Interest Rate on Debt % Related Terms


Premier Biomedical Effective Interest Rate on Debt % Historical Data

* Premium members only.

The historical data trend for Premier Biomedical's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Premier Biomedical Effective Interest Rate on Debt % Chart

Premier Biomedical Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Effective Interest Rate on Debt %
Get a 7-Day Free Trial Premium Member Only 455.17 53.33 199.43 162.50 166.88

Premier Biomedical Quarterly Data
Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19
Effective Interest Rate on Debt % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 87.30 7.10 60.44 101.36 659.49

BIEI vs PTXTQ, STNN, SBFM: Effective Interest Rate on Debt % Comparison

For the Specialty Chemicals subindustry, Premier Biomedical's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Premier Biomedical Effective Interest Rate on Debt % vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Premier Biomedical's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Premier Biomedical's Effective Interest Rate on Debt % falls into.



Premier Biomedical Effective Interest Rate on Debt % Calculation

Premier Biomedical's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Dec. 2019 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (A: Dec. 2018 )+Total Debt  (A: Dec. 2019 ))/ count )
=-1  *  -0.393/( (0.31+0.161)/ 2 )
=-1  *  -0.393/0.2355
=166.88 %

where

Premier Biomedical's annualized Effective Interest Rate on Debt % for the quarter that ended in Dec. 2019 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (Q: Sep. 2019 )+Total Debt  (Q: Dec. 2019 ))/ count )
=-1  *  -1.164/( (0.192+0.161)/ 2 )
=-1  *  -1.164/0.1765
=659.49 %

where

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Dec. 2019) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

What does a Effective Interest Rate on Debt % of 659.49% mean?
Premier Biomedical (BIEI) has a Effective Interest Rate on Debt % of 659.49% as of Dec. 2019. Effective interest rate on debt is the rate a company actually pays on its debt. View historical data on Premier Biomedical and its competitors.
Is Premier Biomedical's Effective Interest Rate on Debt % too high?
Premier Biomedical's current Effective Interest Rate on Debt % is 659.49%.
How does Premier Biomedical's Effective Interest Rate on Debt % compare to PTXTQ and STNN?
Premier Biomedical's Effective Interest Rate on Debt % of 659.49% can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Effective Interest Rate on Debt % for a Chemicals company?
A good Effective Interest Rate on Debt % depends on the Chemicals industry context. However, Effective Interest Rate on Debt % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Effective Interest Rate on Debt % mean?
A high Effective Interest Rate on Debt % can signal that a stock is expensive relative to its fundamentals. Effective interest rate on debt is the rate a company actually pays on its debt. View historical data on Premier Biomedical and its competitors. Premier Biomedical's current Effective Interest Rate on Debt % is 659.49%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Premier Biomedical stock overvalued right now?
Premier Biomedical (BIEI) has a current Effective Interest Rate on Debt % of 659.49%. The current Effective Interest Rate on Debt % is 659.49%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Effective Interest Rate on Debt % calculated?
Effective Interest Rate on Debt % is calculated from a company's financial statements. For Premier Biomedical (BIEI), the current Effective Interest Rate on Debt % is 659.49% as of Dec. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Premier Biomedical Business Description

Address 1150 S. 8th Street, El Centro, CA, USA, 92243
Premier Biomedical Inc is engaged in a hemp based initiative, developing graphene enhanced formulations for a myriad of commercial and military applications and complementing new EV battery technology.